85 results
Page 2 of 5
8-K
EX-99.1
vozegc9rvif3ol92vy8s
9 Aug 22
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2022 Financial Results
7:15am
424B5
n1onma
15 Jun 22
Prospectus supplement for primary offering
5:16pm
424B5
ebnrh2l
13 Jun 22
Prospectus supplement for primary offering
6:11am
8-K
EX-99.1
zb0s89o4jxaa
10 May 22
Cogent Biosciences Reports Recent Business Highlights and First Quarter
7:31am
8-K
EX-99.1
skrb4fu wubfypj
15 Mar 22
Cogent Biosciences Provides Corporate Updates, Fourth Quarter
8:08am
8-K
EX-99.1
17d0e610nav
10 Nov 21
Cogent Biosciences Provides Corporate Updates and Reports Third Quarter 2021 Financial Results
8:05am
8-K
EX-99.1
qwk9 o5yvax
16 Aug 21
Cogent Biosciences Provides Corporate Updates and Reports Second Quarter 2021 Financial Results
7:12am
8-K
EX-10.1
dlw d0ybjakkz
9 Jul 21
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-99.1
7stejc
12 May 21
Cogent Biosciences Provides Corporate Updates and Reports First Quarter 2021 Financial Results
7:14am
8-K
EX-99.1
bejq5hgv n7ozwf
16 Mar 21
Cogent Biosciences Reports Fourth Quarter 2020
7:15am
424B5
o1cw6i
2 Dec 20
Prospectus supplement for primary offering
5:06pm